Laboratory Medicine ›› 2018, Vol. 33 ›› Issue (11): 1018-1025.DOI: 10.3969/j.issn.1673-8640.2018.011.011
• Orginal Article • Previous Articles Next Articles
SHEN Min1, YANG Xiaodong1, WANG Lin1, ZOU Jihua1, ZHANG Man2, ZOU Bingde1
Received:
2018-01-04
Online:
2018-11-30
Published:
2018-11-28
CLC Number:
SHEN Min, YANG Xiaodong, WANG Lin, ZOU Jihua, ZHANG Man, ZOU Bingde. Establishment and performance evaluation of candidate reference measurement procedure for serum total homocysteine by liquid chromatography-tandem mass spectrometry[J]. Laboratory Medicine, 2018, 33(11): 1018-1025.
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.shjyyx.com/EN/10.3969/j.issn.1673-8640.2018.011.011
名称 | 定量/ 定性 | 母离子(m/z) | 子离子(m/z) | 去簇电压(V) | 碰撞能量(V) |
---|---|---|---|---|---|
Hcy | 定量 | 136.1 | 90.0 | 44 | 15 |
定性 | 136.1 | 118.0 | 44 | 10 | |
Hcy-d4 | 定量 | 140.1 | 94.0 | 40 | 15 |
定性 | 140.1 | 122.1 | 40 | 11 |
名称 | 定量/ 定性 | 母离子(m/z) | 子离子(m/z) | 去簇电压(V) | 碰撞能量(V) |
---|---|---|---|---|---|
Hcy | 定量 | 136.1 | 90.0 | 44 | 15 |
定性 | 136.1 | 118.0 | 44 | 10 | |
Hcy-d4 | 定量 | 140.1 | 94.0 | 40 | 15 |
定性 | 140.1 | 122.1 | 40 | 11 |
样本名称 | 理论浓度(nmol/g) | 样本数 | 测定均值(nmol/g) | 平均S/N | CV(%) | 偏移(%) |
---|---|---|---|---|---|---|
定量限样本1 | 0.31 | 10 | 0.33 | 16 | 9.72 | 6.45 |
定量限样本2 | 0.51 | 10 | 0.53 | 24 | 7.81 | 3.92 |
定量限样本3 | 0.76 | 10 | 0.78 | 38 | 5.57 | 2.63 |
样本名称 | 理论浓度(nmol/g) | 样本数 | 测定均值(nmol/g) | 平均S/N | CV(%) | 偏移(%) |
---|---|---|---|---|---|---|
定量限样本1 | 0.31 | 10 | 0.33 | 16 | 9.72 | 6.45 |
定量限样本2 | 0.51 | 10 | 0.53 | 24 | 7.81 | 3.92 |
定量限样本3 | 0.76 | 10 | 0.78 | 38 | 5.57 | 2.63 |
样本 | 批次 | 平均值(μmol/L) | 批内CV(%) | 总体平均值(μmol/L) | 批间CV(%) |
---|---|---|---|---|---|
混合血清1 | 1 | 11.33 | 1.54 | 11.24 | 0.76 |
2 | 11.18 | 1.22 | |||
3 | 11.19 | 1.72 | |||
混合血清2 | 1 | 48.72 | 1.29 | 48.83 | 0.22 |
2 | 48.84 | 1.29 | |||
3 | 48.93 | 0.98 | |||
混合血清3 | 1 | 81.41 | 1.00 | 81.68 | 0.28 |
2 | 81.81 | 1.18 | |||
3 | 81.80 | 1.51 |
样本 | 批次 | 平均值(μmol/L) | 批内CV(%) | 总体平均值(μmol/L) | 批间CV(%) |
---|---|---|---|---|---|
混合血清1 | 1 | 11.33 | 1.54 | 11.24 | 0.76 |
2 | 11.18 | 1.22 | |||
3 | 11.19 | 1.72 | |||
混合血清2 | 1 | 48.72 | 1.29 | 48.83 | 0.22 |
2 | 48.84 | 1.29 | |||
3 | 48.93 | 0.98 | |||
混合血清3 | 1 | 81.41 | 1.00 | 81.68 | 0.28 |
2 | 81.81 | 1.18 | |||
3 | 81.80 | 1.51 |
样本 | 理论浓度(nmol/g) | 实测浓度(nmol/g) | 回收率(%) | CV(%) |
---|---|---|---|---|
加标样本1 | 30.58 | 30.52 | 99.8 | 1.03 |
加标样本2 | 49.21 | 49.33 | 100.2 | 0.66 |
加标样本3 | 65.42 | 65.96 | 100.8 | 0.35 |
样本 | 理论浓度(nmol/g) | 实测浓度(nmol/g) | 回收率(%) | CV(%) |
---|---|---|---|---|
加标样本1 | 30.58 | 30.52 | 99.8 | 1.03 |
加标样本2 | 49.21 | 49.33 | 100.2 | 0.66 |
加标样本3 | 65.42 | 65.96 | 100.8 | 0.35 |
条件 | 理论浓度(μmol/L) | 实测浓度(μmol/L) | 回收率(%) |
---|---|---|---|
室温放置 | |||
4 h | 11.24 | 11.32 | 100.71 |
8 h | 11.24 | 11.22 | 99.82 |
12 h | 11.24 | 11.37 | 101.16 |
24 h | 11.24 | 11.41 | 101.51 |
2~8 ℃放置 | |||
1 d | 11.24 | 11.30 | 100.53 |
2 d | 11.24 | 11.43 | 101.69 |
3 d | 11.24 | 11.33 | 100.80 |
4 d | 11.24 | 11.26 | 100.18 |
反复冻融 | |||
1次 | 11.24 | 11.31 | 100.62 |
2次 | 11.24 | 11.34 | 100.89 |
3次 | 11.24 | 11.50 | 102.31 |
5次 | 11.24 | 11.47 | 102.05 |
条件 | 理论浓度(μmol/L) | 实测浓度(μmol/L) | 回收率(%) |
---|---|---|---|
室温放置 | |||
4 h | 11.24 | 11.32 | 100.71 |
8 h | 11.24 | 11.22 | 99.82 |
12 h | 11.24 | 11.37 | 101.16 |
24 h | 11.24 | 11.41 | 101.51 |
2~8 ℃放置 | |||
1 d | 11.24 | 11.30 | 100.53 |
2 d | 11.24 | 11.43 | 101.69 |
3 d | 11.24 | 11.33 | 100.80 |
4 d | 11.24 | 11.26 | 100.18 |
反复冻融 | |||
1次 | 11.24 | 11.31 | 100.62 |
2次 | 11.24 | 11.34 | 100.89 |
3次 | 11.24 | 11.50 | 102.31 |
5次 | 11.24 | 11.47 | 102.05 |
条件 | 理论浓度(μmol/L) | 实测浓度(μmol/L) | 回收率(%) |
---|---|---|---|
室温放置 | |||
4 h | 11.24 | 11.27 | 100.27 |
8 h | 11.24 | 11.32 | 100.71 |
12 h | 11.24 | 11.41 | 101.51 |
24 h | 11.24 | 11.36 | 101.07 |
自动进样器放置(10 ℃) | |||
4 h | 11.24 | 11.17 | 99.38 |
8 h | 11.24 | 11.25 | 100.09 |
12 h | 11.24 | 11.32 | 100.71 |
24 h | 11.24 | 11.40 | 101.42 |
条件 | 理论浓度(μmol/L) | 实测浓度(μmol/L) | 回收率(%) |
---|---|---|---|
室温放置 | |||
4 h | 11.24 | 11.27 | 100.27 |
8 h | 11.24 | 11.32 | 100.71 |
12 h | 11.24 | 11.41 | 101.51 |
24 h | 11.24 | 11.36 | 101.07 |
自动进样器放置(10 ℃) | |||
4 h | 11.24 | 11.17 | 99.38 |
8 h | 11.24 | 11.25 | 100.09 |
12 h | 11.24 | 11.32 | 100.71 |
24 h | 11.24 | 11.40 | 101.42 |
样本 | 测定结果(μmol/L) | 扩展不确定度 (μmol/L) | 相对扩展不确定度(%) |
---|---|---|---|
混合血清1 | 11.24 | 0.43 | 3.76 |
混合血清2 | 48.83 | 1.59 | 3.26 |
混合血清3 | 81.68 | 3.00 | 3.67 |
样本 | 测定结果(μmol/L) | 扩展不确定度 (μmol/L) | 相对扩展不确定度(%) |
---|---|---|---|
混合血清1 | 11.24 | 0.43 | 3.76 |
混合血清2 | 48.83 | 1.59 | 3.26 |
混合血清3 | 81.68 | 3.00 | 3.67 |
[1] | GANGULY P,ALAM S F.Role of homocysteine in the development of cardiovascular disease[J]. Nutr J,2015,14:6. |
[2] | WALD D S,LAW M,MORRIS J K.Homocysteine and cardiovascular disease: evidence on causality from a meta-analysis[J]. BMJ,2002,325(7374):1202. |
[3] | Homocysteine Studies Collaboration.Homocysteine and risk of ischemic heart disease and stroke: a meta-analysis[J]. JAMA,2002, 288(16):2015-2022. |
[4] | SHENOY V,MEHENDALE V,PRABHU K,et al.Correlation of serum homocysteine levels with the severity of coronary artery disease[J]. Indian J Clin Biochem,2014,29(3):339-344. |
[5] | VERDOIA M,SCHAFFER A,PERGOLINI P,et al.Homocysteine levels influence platelet reactivity in coronary artery disease patients treated with acetylsalicylic acid[J]. J Cardiovasc Pharmacol,2015,66(1):35-40. |
[6] | CHOI J W,LEE M H,FUJII T,et al.Association of the urine homocysteine/creatinine ratio to proinflammatory cytokine, natural anticoagulant, and nitric oxide levels in cerebrovascular disease[J]. Ann Clin Lab Sci,2014,44(4):461-465. |
[7] | ALVAREZ B,YUGUEROS X,FERNÁNDEZ E,et al. Relationship between plasma homocysteine and the morphological and immunohistochemical study of carotid plaques in patients with carotid stenosis over 70%[J]. Ann Vasc Surg,2012,26(4):500-505. |
[8] | 莫惠芳,张爱伦,吴炯,等. 同型半胱氨酸在糖尿病大血管病变中的意义及危险因素分析[J]. 中华检验医学杂志,2017,40(7):526-531. |
[9] | HOTOLEANU C,POROJAN-IUGA M,RUSU M L,et al.Hyperhomocysteinemia: clinical and therapeutical involvement in venous thrombosis[J]. Rom J Intern Med,2007,45(2):159-164. |
[10] | MOURAVAS H,VERETTAS D,KAZAKOS K,et al.Homocysteine and its relationship to deep venous thrombosis in patients undergoing total knee or hip arthroplasty[J]. Hippokratia,2010,14(3):185-188. |
[11] | MANSOOR M A,BERGMARK C,SVARDAL A M,et al.Redox status and protein binding of plasma homocysteine and other aminothiols in patients with early-onset peripheral vascular disease. Homocysteine and peripheral vascular disease[J]. Arterioscler Thromb Vasc Biol,1995,15(2):232-240. |
[12] | LONATI S,NOVEMBRINO C,IPPOLITO S,et al.Analytical performance and method comparison study of the total homocysteine fluorescence polarization immunoassay (FPIA) on the AxSYM analyzer[J]. Clin Chem Lab Med,2004,42(2):228-234. |
[13] | NOLIN T D,MCMENAMIN M E,HIMMELFARB J.Simultaneous determination of total homocysteine, cysteine, cysteinylglycine, and glutathione in human plasma by high-performance liquid chromatography: application to studies of oxidative stress[J]. J Chromatogr B Analyt Technol Biomed Life Sci,2007,852(1-2):554-561. |
[14] | WINDELBERG A,ARSETH O,KVALHEIM G,et al.Automated assay for the determination of methylmalonic acid, total homocysteine, and related amino acids in human serum or plasma by means of methylchloroformate derivatization and gas chromatography-mass spectrometry[J]. Clin Chem,2005,51(11):2103-2109. |
[15] | HANSON N Q,ECKFELDT J H,SCHWICHTENBERG K,et al.Interlaboratory variation of plasma total homocysteine measurements: results of three successive homocysteine proficiency testing surveys[J]. Clin Chem,2002,48(9):1539-1545. |
[16] | LI S,JIA J,LIU G,et al.Improved and simplified LC-ESI-MS/MS method for homocysteine determination in human plasma: application to the study of cardiovascular diseases[J]. J Chromatogr B Analyt Technol Biomed Life Sci,2008,870(1):63-67. |
[17] | TOMAIUOLO M,VECCHIONE G,MARGAGLIONE M.Stable-isotope dilution LC-ESI-MS/MS techniques for the quantification of total homocysteine in human plasma[J]. J Chromatogr B Analyt Technol Biomed Life Sci,2009,877(28):3292-3299. |
[18] | 陈文祥,申子瑜,杨振华. 临床生化检验参考方法及其主要分析原理[J]. 中华检验医学杂志,2007,30(3):245-248. |
[19] | SATTERFIELD M B,SNIEGOSKI L T,WELCH M J,et al.Comparison of isotope dilution mass spectrometry methods for the determination of total homocysteine in plasma and serum[J]. Anal Chem,2003,75(17):4631-4638. |
[20] | NELSON B C,PFEIFFER C M,SNIEGOSKI L T,et al.Development and evaluation of an isotope dilution LC/MS method for the determination of total homocysteine in human plasma[J]. Anal Chem,2003,75(4):775-784. |
[21] | Clinical and Laboratory Standards Institute. Liquid chromatography-mass spectrometry methods[S]. C62-A,CLSI,2014. |
[22] | Clinical and Laboratory Standards Institute. Mass spectrometry in the clinical laboratory: general principles and guidance[S]. C50-A,CLSI,2007. |
[23] | MINEVA E M,SCHLEICHER R L,CHAUDHARY-WEBB M,et al.A candidate reference measurement procedure for quantifying serum concentrations of 25-hydroxyvitamin D3 and 25-hydroxyvitamin D2 using isotope-dilution liquid chromatography-tandem mass spectrometry[J]. Anal Bioanal Chem,2015,407(19):5615-5624. |
[1] | TAN Chunyan, ZHOU Ying, MO Zhijiang. Errors in Appendix B examples of WS/T 505—2017 and correction [J]. Laboratory Medicine, 2023, 38(6): 569-573. |
[2] | YANG Xiaodong, LI Quanle, PAN Qingqing, ZHOU Jing, XIE Yangmin, ZOU Jihua, SHEN Min, ZHANG Man. Establishment and performance evaluation of candidate reference measurement procedure for the determination of immunosuppressive drugs in human whole blood by ID-LC-MS/MS [J]. Laboratory Medicine, 2023, 38(3): 215-222. |
[3] | JIN Zhonggan, JU Yi, ZHANG Sujie. Analysis of homocysteine trueness verification results in 2021 [J]. Laboratory Medicine, 2023, 38(10): 967-970. |
[4] | LIU Congcong, LI Jiaping, ZHOU Hongwei. Performance evaluation of 2 mass spectrometry systems in clinical microbial identification [J]. Laboratory Medicine, 2022, 37(11): 1084-1088. |
[5] | TIAN Yueru, WANG Jingjing, AI Fuqi, MA Yimin, WANG Bei, JIANG Xiaofei. Performance evaluation of Vitek 2 Compact AST-N334,AST-N335,AST-P639 Chinese antimicrobial susceptibility test cards [J]. Laboratory Medicine, 2021, 36(4): 417-423. |
[6] | JU Yi. Research and application of reference measurement system in laboratory medicine [J]. Laboratory Medicine, 2021, 36(3): 237-239. |
[7] | Clinical Diagnosis and Laboratory Medicine Branch of China Maternal and Child Health Association. Expert consensus on establishment of standards for the performance evaluation of systems for whole blood C-reactive protein determination of Chinese children [J]. Laboratory Medicine, 2021, 36(12): 1201-1205. |
[8] | YUE Chaoyan, DUAN Chaohui, ZHANG Di, WEI Jie, LUO Xiaohong, ZHANG Qianlan, WU Yong, YING Chunmei. Performance evaluation of acridinium ester labeled direct chemiluminescence method for the detection of AMH and establishment of adult female AMH reference interval [J]. Laboratory Medicine, 2021, 36(1): 95-100. |
[9] | SONG Jingchen, ZENG Jie, CHEN Tong, ZHANG Chuanbao, PAN Qi, LI Chuanbao, WU Quanying, TANG Dandan, WANG Qin. Performance evaluation of portable glucometers in a hospital of Beijing [J]. Laboratory Medicine, 2020, 35(11): 1186-1189. |
[10] | LIU Yang, ZHANG Zhiping, PENG Daorong, SONG Liuwei, GE Shengxiang, HAO Xiaoke, LIU Jiayun. Establishment and performance evaluation of chemiluminescent microparticle immunoassay for the determination of high concentration HbsAg [J]. Laboratory Medicine, 2020, 35(10): 1056-1061. |
[11] | LIU Huiling, WANG Bing, ZHANG Ying, ZHU Jiawen, OUYANG Qinghui. Differences of sigma performance evaluation by using allowable total errors and biases from different sources [J]. Laboratory Medicine, 2019, 34(7): 648-650. |
[12] | LIU Wenbin, JU Yi, TANG Liping, WANG Meijuan, OU Yuanzhu, YU Xiaoxuan, LI Qing. IFCC Secondary Reference Measurement Procedure for 4 HbA1c determination systems [J]. Laboratory Medicine, 2019, 34(5): 443-446. |
[13] | OU Yuanzhu, TANG Liping, YU Xiaoxuan, LIU Wenbin. Performance evaluation of 3 kinds of serum cholinesterase determination kits by manual DGKC method [J]. Laboratory Medicine, 2019, 34(4): 355-359. |
[14] | ZHOU Weiping, DAI Huifen, TAO Yun, WANG Huimin, WANG Jianxin, JI Huoyan, CHEN Feng. Evaluation on the uncertainty of TB reference measurement procedure by GUF [J]. Laboratory Medicine, 2019, 34(11): 1032-1037. |
[15] | LIN Feiran, LIU Wenbin, OU Yuanzhu, YU Xiaoxuan, GE Danhong, TANG Liping. Performance evaluation of different homocysteine determination systems [J]. Laboratory Medicine, 2019, 34(1): 51-55. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||